[Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology.].

@article{Lpez2010ClinicalCO,
  title={[Clinical consensus on respiratory syncytial virus (RSV) infection prophylaxis and the use of palivizumab in paediatric cardiology.].},
  author={Constancio Medrano L{\'o}pez and Luis Garc{\'i}a-Guereta and Luis Fern{\'a}ndez Pineda and Pascual Malo Concepci{\'o}n and E Maroto Alvaro and Jos{\'e} Santos de Soto and J Lirio Casero and Pedro Su{\'a}rez Cabrera and F Caballero Mart{\'i}nez},
  journal={Anales de pediatria},
  year={2010},
  volume={72 6},
  pages={432.e1-13}
}
BACKGROUND Following the results of the CIVIC study, the SECPCC proposes to revise its recommendations for the prevention of RSV, taking into account the new evidence, as well as the preventive experience of paediatric cardiologists. For this purpose a structured method of professional consensus has been chosen. OBJECTIVES To develop a Spanish clinical consensus on preventing infection by RSV under the auspices of the Sociedad Española de Cardiología Pediátrica y Cardiopatías Congénitas… CONTINUE READING